TABLE 5.
Multivariate logistic regression analysis of different baseline demographic and clinical variables associated with the overall presence of stroke/TIA on follow‐up
| Variable | Global P‐value | OR [95% CI] | OR P‐value |
|---|---|---|---|
| Oral anticoagulant treatment | |||
| DOAC vs. no | 0.365 | 0.635 [0.213–1.894] | 0.742 |
| VKA vs. no | 0.565 [0.253–1.262] | 0.380 | |
| AF at baseline or at 1 year | 0.005 | 2.812 [1.361–5.810] | 0.005 |
| History of stroke/TIA | |||
| Stroke vs. no | <0.001 | 7.311 [3.363–15.894] | 0.010 |
| TIA vs. no | 5.749 [2.109–15.674] | 0.143 | |
| Anaemia | 0.006 | 3.119 [1.387–7.014] | 0.006 |
| Sample size: 2394/2583 | |||
| Hosmer–Lemeshow goodness of fit: Stat = 3.55 with 4 d.f. and six groups. P‐value = 0.470 | |||
AF, atrial fibrillation; CI, confidence interval; DOAC, direct oral anticoagulant; OR, odds ratio; TIA, transient ischaemic attack; VKA, vitamin K antagonist.